Archived AES Symposia - Health Services
View a Presentation:
To view a presentation, click on the presentation title.
Presentation Listing:
The following Presentations have been repurposed from the AES Annual Meeting and other Educational activities.
Faculty presentations have been reproduced from the live activity in accordance with faculty copyright
content license agreements. Most courses contain the audio, slides and a written transcript of the presented
program.
| Health Services | |||||
|---|---|---|---|---|---|
| Presentation Title | Speaker | Presentation Date | |||
|
Care of Veterans in the New Epilepsy Centers of Excellence |
Karen Parko, MD |
December 2010 | |||
|
Healthcare Reform: Impact on Care for Individuals with Epilepsy |
David Labiner, MD |
December 2010 | |||
|
How Are Epilepsy Resources Allocated Around the World? Lessons From Epilepsy Surgery Part 2 Speaker Interview Unavailable |
Samuel Wiebe, MD |
December 2010 | |||
|
How Are Epilepsy Resources Allocated Around the World? Lessons From Epilepsy Surgery Part 1 |
Frans Leijten, MD, PhD |
December 2010 | |||
|
Introduction and Overview - ILAE |
Sheryl Haut, MD |
December 2010 | |||
|
Living with Epilepsy in the Current System |
Lisa Moss. M.D. |
December 2010 | |||
|
Healthcare Reform Legislation: Impact on Epilepsy |
David Labiner, MD |
December 2010 | |||
|
Healthcare Reform Legislation: Impact on Epilepsy Care Speaker Interview Unavailable |
Carly Kelly |
December 2010 | |||
Disclosure: It is the policy of the American Epilepsy Society that all faculty participating in continuing medical education activities are expected to disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. The American Epilepsy Society adheres to the ACCME's Essential Areas and Policies regarding industry support of continuing medical education. Disclosure by faculty of commercial relationships, if any, and discussions of unlabeled or unapproved uses will be made.
Disclaimer: Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by the American Epilepsy Society or any manufacturers of pharmaceuticals.